Douglas G. Cole
Director, AVEO PHARMACEUTICALS, INC.
Companies
- Foghorn Therapeutics Inc.Board member Oct 22, 2020 to now1
- Sana BiotechnologyBoard member Feb 3, 2021 to Jul 15, 20242
- Sigilon Therapeutics, Inc.Board member Dec 3, 2020 to Aug 11, 20233
- Denali Therapeutics Inc.Board member Dec 7, 2017 to Jun 5, 20234
- Quanterix (United States)Board member Dec 6, 2017 to Jan 4, 20195
- Editas MedicineBoard member Feb 2, 2016 to Aug 21, 20176
- Agios PharmaceuticalsBoard member Jul 23, 2013 to Aug 11, 20167
- Tetraphase Pharmaceuticals (United States)Board member Mar 19, 2013 to May 20, 20138
- AVEO PHARMACEUTICALS, INC.Board member Mar 11, 2010 to May 16, 20119
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSana Biotechnology, Board member
- 3
- 4
- 5
- 6SEC EDGAREditas Medicine, Board member
- 7SEC EDGARAgios Pharmaceuticals, Board member
- 8
- 9